A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/00 (2006.01) A61K 38/22 (2006.01) C07K 16/26 (2006.01)
Patent
CA 2458883
Inflammation or damage associated with myocardial events is treated or prevented by administration of an angiogenesis-inducing, anti-inflammatory peptide such as Thymosin .beta.4, an isoform of Thymosin .beta.4 or oxidized Thymosin .beta.4.
On traite ou on prévient l'inflammation ou la détérioration associée à des événements myocardiques par administration d'un peptide anti-inflammatoire induisant l'angiogenèse, tel que thymosine beta 4, une isoforme de thymosine beta 4 ou thymosine beta 4 oxydée.
Finkelstein Jack Jr.
Goldstein Allan L.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Regenerx Biopharmaceuticals Inc.
LandOfFree
Methods of treating mycocardial event related conditions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating mycocardial event related conditions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating mycocardial event related conditions... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1735063